recent news

Giiant Pharma Inc extended its Seed round with AQC Capital and CQDM to ensure reaching clinical proof-of-concept

giiant pharma inc strengthens its Board of Directors with the appointment of Dr. Marie Lindner

giiant pharma inc announced the closing of US$11M in Seed financing to develop its Precision Delivery technology platform in gastroenterology.